Trial intelligence / Profile preview

Intravenous paracetamol for labour analgesia in primigravida women

IRCT20220308054220N1Phase 3Completed

Sponsor
Rawalpindi Medical University
Start
May 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial comparing Placebo control with Intravenous paracetamol (2 arms). Primary endpoint: Pain assessment by Visual Analogue Scale. Started May 2022; status: completed.

02

Drugs

acetaminophen

Beyond the preview

Go deeper on IRCT20220308054220N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220308054220N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call